In the BioHarmony Drug Report Database
Clioquinol
Nystaform (clioquinol) is a small molecule pharmaceutical. Clioquinol was first approved as Nystaform on 1982-01-01. It is used to treat acneiform eruptions, dermatitis, folliculitis, lichenoid eruptions, and tinea pedis in the USA.
Trade Name
|
Nystaform |
|---|---|
Common Name
|
clioquinol |
ChEMBL ID
|
CHEMBL497 |
Indication
|
acneiform eruptions, dermatitis, folliculitis, lichenoid eruptions, tinea pedis |
Drug Class
|
Image (chem structure or protein)